View Item 

Show simple item record

Mailed Outreach Invitations Significantly Improve HCC Surveillance Rates in Patients With Cirrhosis: A Randomized Clinical Trial
dc.contributor.authorSingal, Amit G.
dc.contributor.authorTiro, Jasmin A.
dc.contributor.authorMurphy, Caitlin C.
dc.contributor.authorMarrero, Jorge A.
dc.contributor.authorMcCallister, Katharine
dc.contributor.authorFullington, Hannah
dc.contributor.authorMejias, Caroline
dc.contributor.authorWaljee, Akbar K.
dc.contributor.authorPechero Bishop, Wendy
dc.contributor.authorSantini, Noel O.
dc.contributor.authorHalm, Ethan A.
dc.date.accessioned2019-01-15T20:32:11Z
dc.date.available2020-03-03T21:29:35Zen
dc.date.issued2019-01
dc.identifier.citationSingal, Amit G.; Tiro, Jasmin A.; Murphy, Caitlin C.; Marrero, Jorge A.; McCallister, Katharine; Fullington, Hannah; Mejias, Caroline; Waljee, Akbar K.; Pechero Bishop, Wendy; Santini, Noel O.; Halm, Ethan A. (2019). "Mailed Outreach Invitations Significantly Improve HCC Surveillance Rates in Patients With Cirrhosis: A Randomized Clinical Trial." Hepatology (1): 121-130.
dc.identifier.issn0270-9139
dc.identifier.issn1527-3350
dc.identifier.urihttps://hdl.handle.net/2027.42/147207
dc.publisherWiley Periodicals, Inc.
dc.titleMailed Outreach Invitations Significantly Improve HCC Surveillance Rates in Patients With Cirrhosis: A Randomized Clinical Trial
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelInternal Medicine and Specialties
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/147207/1/hep30129-sup-0001-Appendix.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/147207/2/hep30129_am.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/147207/3/hep30129.pdf
dc.identifier.doi10.1002/hep.30129
dc.identifier.sourceHepatology
dc.identifier.citedreferenceBeste LA, Ioannou GN, Yang Y, Chang MF, Ross D, Dominitz JA. Improved surveillance for hepatocellular carcinoma with a primary care‐oriented clinical reminder. Clin Gastroenterol Hepatol 2015; 13: 172 ‐ 179.
dc.identifier.citedreferenceSingal AG, Gupta S, Skinner CS, Ahn C, Santini NO, Agrawal D, et al. Effect of colonoscopy outreach vs fecal immunochemical test outreach on colorectal cancer screening completion: a randomized clinical trial. JAMA 2017; 318: 806 ‐ 815.
dc.identifier.citedreferenceSingal AG, Tiro JA, Marrero JA, McCallister K, Mejias C, Adamson B, et al. Mailed outreach program increases ultrasound screening of patients with cirrhosis for hepatocellular carcinoma. Gastroenterology 2017; 152: 608 ‐ 615,e604.
dc.identifier.citedreferenceSingal AG, Yopp AC, Gupta S, Skinner CS, Halm EA, Okolo E, et al. Failure rates in the hepatocellular carcinoma surveillance process. Cancer Prev Res (Phila) 2012; 5: 1124 ‐ 1130.
dc.identifier.citedreferenceNehra MS, Ma Y, Clark C, Amarasingham R, Rockey DC, Singal AG. Use of administrative claims data for identifying patients with cirrhosis. J Clin Gastroenterol 2013; 47: e50 ‐ e54.
dc.identifier.citedreferenceAbd El Rihim AY, Omar RF, Fathalah W, El Attar I, Hafez HA, Ibrahim W. Role of fibroscan and APRI in detection of liver fibrosis: a systematic review and meta‐analysis. Arab J Gastroenterol 2013; 14: 44 ‐ 50.
dc.identifier.citedreferenceTrevisani F, De Notariis S, Rapaccini G, Farinati F, Benvegnù L, Zoli M, et al. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience). Am J Gastroenterol 2002; 97: 734 ‐ 744.
dc.identifier.citedreferenceMokdad A, Browning T, Mansour JC, Zhu H, Singal AG, Yopp AC. Implementation of a voice messaging system is associated with improved time‐to‐treatment and overall survival in patients with hepatocellular carcinoma. J Natl Compr Canc Netw 2016; 14: 38 ‐ 46.
dc.identifier.citedreferenceTzartzeva K, Obi J, Rich NE, Parikh ND, Marrero JA, Yopp A, et al. Surveillance imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in cirrhosis: a meta‐analysis. Gastroenterology 2018; 154: 1706 ‐ 1718.e1.
dc.identifier.citedreferenceWigg AJ, McCormick R, Wundke R, Woodman RJ. Efficacy of a chronic disease management model for patients with chronic liver failure. Clin Gastroenterol Hepatol 2013; 11: 850 ‐ 858,e851‐854.
dc.identifier.citedreferenceSingal AG, Li X, Tiro J, Kandunoori P, Adams‐Huet B, Nehra MS, et al. Racial, social, and clinical determinants of hepatocellular carcinoma surveillance. Am J Med 2015; 128: e1 ‐ 7.
dc.identifier.citedreferenceDalton‐Fitzgerald E, Tiro J, Kandunoori P, Halm EA, Yopp A, Singal AG. Practice patterns and attitudes of primary care providers and barriers to surveillance of hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol 2015; 13: 791 ‐ 798.
dc.identifier.citedreferenceSimmons OL, Feng Y, Parikh ND, Singal AG. Primary care provider practice patterns and barriers to hepatocellular carcinoma surveillance. Clin Gastroenterol Hepatol In press.
dc.identifier.citedreferenceLok AS, Seeff LB, Morgan TR, di Bisceglie AM, Sterling RK, Curto TM, et al. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C‐related advanced liver disease. Gastroenterology 2009; 136: 138 ‐ 148.
dc.identifier.citedreferenceAscha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, Zein NN. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 2010; 51: 1972 ‐ 1978.
dc.identifier.citedreferenceSingal AG, Tiro JA, Gupta S. Improving hepatocellular carcinoma screening: applying lessons from colorectal cancer screening. Clin Gastroenterol Hepatol 2013; 11: 472 ‐ 477.
dc.identifier.citedreferencePatel N, Yopp AC, Singal AG. Diagnostic delays are common among patients wtih hepatocellular carcinoma. J Natl Compr Canc Netw 2015; 13: 543 ‐ 549.
dc.identifier.citedreferenceSingal AG, Waljee AK, Patel N, Chen EY, Tiro JA, Marrero JA, et al. Therapeutic delays lead to worse survival among patients with hepatocellular carcinoma. J Natl Compr Canc Netw 2013; 11: 1101 ‐ 1108.
dc.identifier.citedreferenceSingal A, Volk M, Rakoski MO, Fu S, Su GL, McCurdy H, et al. Patient involvement in healthcare is associated with higher rates of surveillance for hepatocellular carcinoma. J Clin Gastroenterol 2011; 45: 727 ‐ 732.
dc.identifier.citedreferenceFarvardin S, Patel J, Khambaty M, Yerokun OA, Mok H, Tiro JA, et al. Patient‐reported barriers are associated with lower hepatocellular carcinoma surveillance rates in patients with cirrhosis. Hepatology 2017; 65: 875 ‐ 884.
dc.identifier.citedreferencePercac‐Lima S, Ashburner JM, Zai AH, Chang Y, Oo SA, Guimaraes E, et al. Patient navigation for comprehensive cancer screening in high‐risk patients using a population‐based health information technology system: a randomized clinical trial. JAMA Intern Med 2016; 176: 930 ‐ 937.
dc.identifier.citedreferenceArtinyan A, Mailey B, Sanchez‐Luege N, Khalili J, Sun CL, Bhatia S, et al. Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States. Cancer 2010; 116: 1367 ‐ 1377.
dc.identifier.citedreferenceRich NE, Hester C, Odewole M, Murphy C, Parikh ND, Marrero JA, et al. Racial and ethnic differences in hepatocellular carcinoma presentation and outcomes. Clin Gastroenterol Hepatol In press.
dc.identifier.citedreferenceBertuccio P, Turati F, Carioli G, Rodriguez T, La Vecchia C, Malvezzi M, et al. Global trends and predictions in hepatocellular carcinoma mortality. J Hepatol 2017; 67: 302 ‐ 309.
dc.identifier.citedreferenceEl‐Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012; 142: 1264 ‐ 1273,e1261.
dc.identifier.citedreferenceBruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2010; 53: 1 ‐ 35.
dc.identifier.citedreferenceZhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 2004; 130: 417 ‐ 422.
dc.identifier.citedreferenceSingal AG, Pillai A, Tiro J. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta‐analysis. PLoS Med 2014; 11: e1001624.
dc.identifier.citedreferenceSingal AG, Mittal S, Yerokun OA, Ahn C, Marrero JA, Yopp AC, et al. Hepatocellular carcinoma screening associated with early tumor detection and improved survival among patients with cirrhosis in the US. Am J Med 2017; 130: 1099 ‐ 1106,e1091.
dc.identifier.citedreferencevan Meer S, de Man RA, Coenraad MJ, Sprengers D, van Nieuwkerk KM, Klümpen HJ, et al. Surveillance for hepatocellular carcinoma is associated with increased survival: results from a large cohort in the Netherlands. J Hepatol 2015; 63: 1156 ‐ 1163.
dc.identifier.citedreferenceBreen N, Meissner HI. Toward a system of cancer screening in the United States: trends and opportunities. Annu Rev Public Health 2005; 26: 561 ‐ 582.
dc.identifier.citedreferenceSingal AG, Yopp A, C SS, Packer M, Lee WM, Tiro JA. Utilization of hepatocellular carcinoma surveillance among American patients: a systematic review. J Gen Intern Med 2012; 27: 861 ‐ 867.
dc.identifier.citedreferenceSingal AG, Tiro J, Li X, Adams‐Huet B, Chubak J. Hepatocellular carcinoma surveillance among patients with cirrhosis in a population‐based integrated health care delivery system. J Clin Gastroenterol 2017; 51: 650 ‐ 655.
dc.identifier.citedreferenceGenoff MC, Zaballa A, Gany F, Gonzalez J, Ramirez J, Jewell ST, et al. Navigating language barriers: a systematic review of patient navigators’ impact on cancer screening for limited English proficient patients. J Gen Intern Med 2016; 31: 426 ‐ 434.
dc.identifier.citedreferenceKrok‐Schoen JL, Oliveri JM, Paskett ED. Cancer care delivery and women’s health: the role of patient navigation. Front Oncol 2016; 6: 2.
dc.identifier.citedreferenceMuliira JK, D’souza MS. Effectiveness of patient navigator interventions on uptake of colorectal cancer screening in primary care settings. Jpn J Nurs Sci 2016; 13: 205 ‐ 219.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
hep30129-sup-0001-Appendix.pdf
Size:
226.4KB
Format:
PDF
View/Open
Name:
hep30129_am.pdf
Size:
286.8KB
Format:
PDF
View/Open
Name:
hep30129.pdf
Size:
257.8KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.